Cellular differentiation of neoplastic cells after exposure to 1,25-dihydroxyvitamin D 3 (1,25 D 3 ) is accompanied by altered cell cycle regulation. In previous studies, blocks in both G 1 /S and G 2 /M checkpoints have been observed in 1,25D 3 -treated HL60 cells, but the mechanism of the 1,25D 3
p53/56lyn antisense shifts the 1,25-dihydroxyvitamin D3–induced G1/S block in HL60 cells to S phase
✍ Scribed by Qing Mei Wang; George P. Studzinski; Fei Chen; Frederick D. Coffman; Lawrence E. Harrison
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 288 KB
- Volume
- 183
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
p53/56 lyn is a member of the src family that is predominantly expressed in hematopoietic cells and is thought to play a role in cellular proliferation. In this study, we demonstrate the participation of p53/56 lyn in 1,25-dihydroxyvitamin D 3 (1,25D 3 )-induced growth arrest in HL60 cells. We show that the mRNA and protein levels of p53/56 lyn are markedly elevated after 1,25D 3 treatment, which is accompanied by an increase of p53/56 lyn kinase activity. We also demonstrate that treatment with p53/56 lyn antisense oligodeoxynucleotides reverses the 1,25D 3 -induced G1/S block, and results in an accumulation of cells with S-phase DNA content. BrdU pulse-chase experiments reveal that this accumulation results from an increased proportion of cells actively synthesizing DNA, which are inhibited from exiting the S-phase compartment. These results indicate that upregulation of p53/56 lyn contributes significantly to the G1/S growth arrest induced by 1,25D 3 in HL60 cells and thus its activation may be a desirable outcome of chemotherapeutic regimens.
📜 SIMILAR VOLUMES